TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 1 | 0 | -8 | -38 | -29 | -28 | -64 | -33 |
| S | %wins | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/18/22 17:36 | 8/16/22 | EIGR | Eiger Biopharmaceuticals, Inc. | Health | BioPrd | Biological Products, (No Diag | Apelian David | CA | D | S | -49 | 9.81 | 0 | -5 | -31 | 11 | D | ||||||||||||||||
12/30/15 16:26 | 12/30/15 | ACHN | Achillion Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Apelian David | CT | O | Chief Me | M.d | 30 | 3.02 | 20 | 10 | 0 | D | 208 | -18 | 18 | 59 | 4 | 6 | 8 | 3 | 0 | -8 | -38 | -29 | -28 | -64 | |
12/30/15 16:26 | 12/30/15 | ACHN | Achillion Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Apelian David | CT | O | Chief Me | S.d | -105 | 10.50 | 20 | -10 | -100 | 0 | D | 208 | -18 | 18 | 59 | 4 | 6 | 8 | 3 | 0 | -8 | -38 | -29 | -28 | -64 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |